Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

RXRXRXRX
Showing 8 of 21 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in RECURSION PHARMACEUTICALS IN

Yes. Susquehanna International Group holds 3,292,128 shares of RXRX (Recursion Pharmaceuticals in), worth $12.1M, as of its Q2 2026 13F filing. It reduced the position by 933,149 shares (-22.1%) from Q1 2026. Susquehanna International Group has held RXRX in every 13F on record since Q2 2021, 21 quarterly filings.

Current Value

$12.1M

Current Shares

3.3M

Total Value Change

+$5M

Total Shares Change

+2.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.3M
-22.1%
$12.1M0.0%$3.67
0
2026-Q1
Decreased
4.2M
-3.9%
$13M0.0%$3.54
0
2025-Q4
Decreased
4.4M
-18.4%
$18M0.0%$4.11
0
2025-Q3
Increased
5.4M
+68.1%
$26.3M0.0%$4.91
42
2025-Q2
Increased
3.2M
+56.4%
$16.2M0.0%$5.03
40
2025-Q1
Increased
2M
+22.9%
$10.8M0.0%$5.81
34
2024-Q4
Increased
1.7M
+55.9%
$11.3M0.0%$6.77
39
2024-Q3
Decreased
1.1M
-21.7%
$7M0.0%$6.98
0

Other major holders of RXRX: BAILLIE GIFFORD & CO, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used